HbA1c and Lipid Profile Indices: Useful for cardiovascular risk prediction in non-diabetics?


Okuturlar Y., Çiçek B., Deniz O. C., Okuturlar Ö., Çelik Ö., Serteser M., ...Daha Fazla

25TH EUROPEAN CONGRESS OF ENDOCRINOLOGY - ECE 2023 - İSTANBUL., İstanbul, Türkiye, 13 - 16 Mayıs 2023, cilt.90, ss.90-91

  • Yayın Türü: Bildiri / Tam Metin Bildiri
  • Cilt numarası: 90
  • Basıldığı Şehir: İstanbul
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.90-91
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Aims: Glycosylated hemoglobin (HbA1c) is a marker which demonstrates 3-month average level of blood glucose level. In individuals with high blood sugar level for a long time is associated with increased risk of cardiovascular disease (CVD). There is a need for simple and cost-effective markers to determine the risk of CVD in primary health care settings. In this study, we aimed to investigate the value of HbA1c for predicting cardiovascular risk in healthy non-diabetic individuals.
Method: 151 healthy individuals who applied to the check-up unit of Acıbadem University Hospital during 2017-2018 period is included in this study. The individuals who has HbA1c level 5.7 and above, and with an estimated glomerular filtration rate below 90 ml/min were excluded.
Results: There was no statistical difference between the mean age, HbA1c and total cholesterol levels of 70 female and 81 male. Though, in male subjects …